The future of Johnson & Johnson's cancer blockbuster Zytiga is in doubt, after a US patent ruling has opened the door to generic competitors. Johnson & Johnson’s Q4 results were hit by a one-off ...

Several generic drugmakers have submitted copycat Zytiga products for approval by the FDA, and one of these – India’s Sun Pharma – claimed approval for its Yonsa generic in May.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Here are the stocks that have reflected the key market trends of 2024 and have been closely watched by investors. This partnership comes after WeaveGrid announced a $28m in funding earlier this ...

An alleged memo to Toyota employees Thursday said it would stop sponsoring LGBTQ events and begin focusing more on “STEM education and workforce readiness." More than 43,-000 Toyota Sequoia ...

After hours: 7:50:06 p.m. EST Loading Chart for TM ...